|
|||||
|
|
Fabry Disease Practice Guidelines: Recommendations of the National Society of Genetic Counselors |
|
| Authors: | Dawn A. Laney Robin L. Bennett Virginia Clarke Angela Fox Robert J. Hopkin Jack Johnson Erin O’Rourke Katherine Sims Gerald Walter |
| Affiliation: | 1. Medical Genetics, Emory University, 2165 North Decatur Road, Decatur, GA, 30033, USA 2. Medical Genetics, University of Washington Medical Center Medical Genetics, Box 357720, Seattle, WA, 98195-7720, USA 3. Massachusetts General Hospital, 185 Cambridge ST, Simches 5236, Boston, MA, 02114, USA 4. Sera Prognostics, 2749 East Parleys Way, Suite 200, Salt Lake City, UT, 84109, USA 5. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 84109, USA 6. Fabry Support and Information Group, 108 NE 2nd St., PO Box 510, Concordia, MO, 64020, USA 7. Genzyme Corporation, Genzyme, 500 Kendall Street, Cambridge, MA, 02142, USA 8. Massachusetts General Hospital/Harvard Medical School, 185 Cambridge St., Simches 5236, Boston, MA, 02114, USA 9. National Fabry Disease Foundation, 4301 Connecticut Ave. N.W., Suite 404, Washington DC, 20008, USA |
| Abstract: | Identification and comprehensive care of individuals who have Fabry disease (FD) requires a multidisciplinary approach inclusive of genetic testing, test interpretation, genetic counseling, long term disease symptom monitoring, treatment recommendations, and coordination of therapy. The purpose of this document is to provide health care professionals with guidelines for testing, care coordination, identification of psychosocial issues, and to facilitate a better understanding of disease treatment expert recommendations for patients with Fabry disease. These recommendations are the opinions of a multicenter working group of genetic counselors, medical geneticists, and other health professionals with expertise in Fabry disease counseling, as well as representatives/founders of the two United States based Fabry disease patient advocacy groups who are themselves affected by Fabry disease. The recommendations are U.S. Preventive Task Force Class III, and they are based on clinical experience, a review of pertinent English-language articles, and reports of expert committees. This document reviews the genetics of Fabry disease, the indications for genetic testing, interpretation of results, psychosocial considerations, and references to professional and patient resources. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |